Literature DB >> 21295139

The interplay between SUCLA2, SUCLG2, and mitochondrial DNA depletion.

Chaya Miller1, Liya Wang, Elsebet Ostergaard, Phyllis Dan, Ann Saada.   

Abstract

SUCLA2-related mitochondrial DNA (mtDNA) depletion syndrome is a result of mutations in the β subunit of the ADP-dependent isoform of the Krebs cycle succinyl-CoA synthase (SCS). The mechanism of tissue specificity and mtDNA depletion is elusive but complementation by the GDP-dependent isoform encoded by SUCLG2, and the association with mitochondrial nucleoside diphosphate kinase (NDPK), is a plausible link. We have investigated this relationship by studying SUCLA2 deficient fibroblasts derived from patients and detected normal mtDNA content and normal NDPK activity. However, knockdown of SUCLG2 by shRNA in both patient and control fibroblasts resulted in a significant decrease in mtDNA amount, decreased NDPK and cytochrome c oxidase activities, and a marked growth impairment. This suggests that, SUCLG2, to a higher degree than SUCLA2, is crucial for mtDNA maintenance and that mitochondrial NDPK is involved. Although results pertain to a cell culture system, the findings might explain the pathomechanism and tissue specificity in mtDNA depletion caused by defective SUCLA2.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21295139     DOI: 10.1016/j.bbadis.2011.01.013

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  23 in total

1.  SUCLG2 identified as both a determinator of CSF Aβ1-42 levels and an attenuator of cognitive decline in Alzheimer's disease.

Authors:  Alfredo Ramirez; Wiesje M van der Flier; Christine Herold; David Ramonet; Stefanie Heilmann; Piotr Lewczuk; Julius Popp; André Lacour; Dmitriy Drichel; Eva Louwersheimer; Markus P Kummer; Carlos Cruchaga; Per Hoffmann; Charlotte Teunissen; Henne Holstege; Johannes Kornhuber; Oliver Peters; Adam C Naj; Vincent Chouraki; Céline Bellenguez; Amy Gerrish; Reiner Heun; Lutz Frölich; Michael Hüll; Lara Buscemi; Stefan Herms; Heike Kölsch; Philip Scheltens; Monique M Breteler; Eckart Rüther; Jens Wiltfang; Alison Goate; Frank Jessen; Wolfgang Maier; Michael T Heneka; Tim Becker; Markus M Nöthen
Journal:  Hum Mol Genet       Date:  2014-07-15       Impact factor: 6.150

Review 2.  Mitochondrial energy generation disorders: genes, mechanisms, and clues to pathology.

Authors:  Ann E Frazier; David R Thorburn; Alison G Compton
Journal:  J Biol Chem       Date:  2017-12-12       Impact factor: 5.157

3.  Valproyl-CoA inhibits the activity of ATP- and GTP-dependent succinate:CoA ligases.

Authors:  Paula B M Luís; Jos Ruiter; Lodewijk IJlst; Isabel Tavares de Almeida; Marinus Duran; Ronald J A Wanders; Margarida F B Silva
Journal:  J Inherit Metab Dis       Date:  2013-10-24       Impact factor: 4.982

Review 4.  Mitochondrial genome changes and neurodegenerative diseases.

Authors:  Milena Pinto; Carlos T Moraes
Journal:  Biochim Biophys Acta       Date:  2013-11-16

5.  Succinyl-CoA synthetase (SUCLA2) deficiency in two siblings with impaired activity of other mitochondrial oxidative enzymes in skeletal muscle without mitochondrial DNA depletion.

Authors:  Xiaoping Huang; Jirair K Bedoyan; Didem Demirbas; David J Harris; Alexander Miron; Simone Edelheit; George Grahame; Suzanne D DeBrosse; Lee-Jun Wong; Charles L Hoppel; Douglas S Kerr; Irina Anselm; Gerard T Berry
Journal:  Mol Genet Metab       Date:  2016-11-12       Impact factor: 4.797

6.  A Novel SUCLA2 Mutation Presenting as a Complex Childhood Movement Disorder.

Authors:  Caterina Garone; Juliana Gurgel-Giannetti; Simone Sanna-Cherchi; Sindu Krishna; Ali Naini; Catarina M Quinzii; Michio Hirano
Journal:  J Child Neurol       Date:  2016-09-28       Impact factor: 1.987

7.  SUCLA2 Deficiency: A Deafness-Dystonia Syndrome with Distinctive Metabolic Findings (Report of a New Patient and Review of the Literature).

Authors:  Roeltje R Maas; Adela Della Marina; Arjan P M de Brouwer; Ron A Wevers; Richard J Rodenburg; Saskia B Wortmann
Journal:  JIMD Rep       Date:  2015-09-27

8.  Effective use of small-interfering RNA to characterize residual B-cell non-Hodgkin lymphoma cells following chemotherapy.

Authors:  Ian K T Kusao; David L Troelstrup; Melissa A Agsalda; Bruce T Shiramizu
Journal:  J Hematol Malig       Date:  2012-03-01

9.  Protein expression profiles of intestinal epithelial co-cultures: effect of functionalised carbon nanotube exposure.

Authors:  Xianyin Lai; Bonnie L Blazer-Yost; James W Clack; Sharry L Fears; Somenath Mitra; Susana Addo Ntim; Heather N Ringham; Frank A Witzmann
Journal:  Int J Biomed Nanosci Nanotechnol       Date:  2013

10.  The GABA transaminase, ABAT, is essential for mitochondrial nucleoside metabolism.

Authors:  Arnaud Besse; Ping Wu; Francesco Bruni; Taraka Donti; Brett H Graham; William J Craigen; Robert McFarland; Paolo Moretti; Seema Lalani; Kenneth L Scott; Robert W Taylor; Penelope E Bonnen
Journal:  Cell Metab       Date:  2015-03-03       Impact factor: 27.287

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.